Skip to content

Internet-Based Cognitive-Behavioral Therapy for Insomnia

Internet-Based Self-Help Cognitive-Behavioral Therapy for Insomnia (CBTI): A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01719120
Enrollment
312
Registered
2012-11-01
Start date
2012-08-31
Completion date
2015-05-31
Last updated
2016-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Keywords

Insomnia, Cognitive-Behavioral Therapy, Internet-Based, Self-Help, Randomized Controlled Trial

Brief summary

The aim of this study is to develop an Internet-based self-help therapy program for insomnia in Chinese language, and to conduct a randomized waiting-list controlled trial on the efficacy of Internet-based self-help therapy for insomnia.

Detailed description

This study is a randomized controlled trial in patients with insomnia. Eligible subjects will be randomly assigned to self-help treatment with telephone consultation (SHTC), self-help treatment without telephone consultation (SH), or waiting-list control. The subjects will receive self-help treatment once per week for 6 consecutive weeks. In addition to self-help treatment, the subjects in SHTC group will receive telephone consultation once per week for 6 consecutive weeks.

Interventions

BEHAVIORALCognitive-Behavioral Therapy

CBT for insomnia aims at changing dysfunctional cognitive beliefs and maladaptive behaviors contributed to the maintenance of insomnia. It involves 4 main components including behavioral, cognitive, educational, and relaxation treatments.

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Hong Kong residents aged ≥18 years * Predominant complaint of difficulty initiating or maintaining sleep or early morning awakening or nonrestorative sleep with associated distress or impairment in social, occupational and other important areas of functioning for at least 3 nights per week for at least 3 months based on self- administered questionnaire * Able to read Chinese and type Chinese or English * Have Internet access (PC/ mobile phone), and with an email address * Willing to give informed consent and comply with the trial protocol

Exclusion criteria

* Have suicidal ideas based on self-report

Design outcomes

Primary

MeasureTime frameDescription
Sleep parameters (sleep onset latency, sleep efficiency, total sleep time, times of wakening during sleep) changes from baseline to 5-week posttreatment by subjective measures using sleep log.Baseline, 1-week, 5-week, and 12-week posttreatment.12-week posttreatment is only for within-group comparison in treatment groups

Secondary

MeasureTime frameDescription
Self-rated sleep-related cognition score measured by Dysfunctional Beliefs and Attitudes about Sleep Scale (DBAS)Baseline, 1-week, 5-week, and 12-week posttreatment.12-week posttreatment is only for within-group comparison in treatment groups
Self-rated severity of depressive and anxiety symptoms measured by Hospital Anxiety and Depression Scale (HADS)Baseline, 1-week, 5-week, and 12-week posttreatment12-week posttreatment is only for within-group comparison in treatment groups
Subjects' general health and quality of life regarding physical functioning, social functioning, physical role limitations, emotional role limitations, mental health, vitality, bodily pain, and general health perception measured by Short form -36 (SF-36)Baseline, 1-week, 5-week, and 12-week posttreatment.12-week posttreatment is only for within-group comparison in treatment groups
Self-rated fatigue score measured by Multidimensional Fatigue Inventory (MFI)Baseline, 1-week, 5-week, and 12-week posttreatment.12-week posttreatment is only for within-group comparison in treatment groups
Self-rated sleep quality score measured by the Pittsburgh Sleep Quality Index (PSQI) questionnaireBaseline, 1-week, 5-week, and 12-week posttreatment.12-week posttreatment is only for within-group comparison in treatment groups
Subjects' adherence to the treatment measured by Treatment adherence rating scale1-week posttreatment
Subjects' satisfaction to the treatment measured by Treatment satisfaction rating scaleTreatment Week 2-6
Potential side effects associated with each component of CBT measured by Symptom checklistTreatment Week 2-6 and 1-week posttreatment
Self-rated sleep quality score changes from baseline to 12-week posttreatment measured by Insomnia Severity Index questionnaireBaseline, treatment Week 3, 1-week, 5-week and 12 week posttreatment.12-week posttreatment is only for within-group comparison in treatment groups
Subjects' acceptability and credibility to the treatment measured by Treatment acceptability and credibility rating scaleBaseline and 1-week posttreatment

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026